LU Yefeng
LU Yefeng
MSN, Nursing specialist, Hepatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Email: yefenglutwo@126.com
Tel: 86-21-68383520
Research areas: Follow up management of liver transplantation; Physical activity of pediatric liver transplantation recipients
Bio
Mr. Lu earned his MSN from Shanghai Jiao Tong University in 2010. His clinical and research focus centers on the pediatric liver transplant population, specifically addressing follow-up management and key indicators such as patient compliance, self-management ability, and quality of life. He authored the Chinese Liver Transplant Follow-Up Technical Specifications (2019 version).
Mr. Lu's achievements include receiving the Third Prize of the 16th Shanghai Nursing Society Science and Technology Award (2024) and the Shanghai Nursing Work Improvement Achievement Award (2021). He has obtained 5 provincial-level, bureau level, and horizontal projects, with a total funding of 300,000 RMB. As first author, he has published 5 research papers in peer-reviewed journals, including Transplantation Proceedings, Asian Journal of Surgery, and Annals of Transplantation. He also serves on the editorial boards of Chinese-language journals such as Nursing Research and General Nursing.
Publications
[1] Lu Y, Yang Y, Wan P, et al. Effect of Preoperative Growth Status on Clinical Outcomes after Living Donor Liver Transplantation in Infants. Transplant Proc, 2017; 49(8): 1848-1854
[2] Huang H, Lu Y, Zhou T, et al. Innate Immune Cells in Immune Tolerance After Liver Transplantation. Front Immunol, 2018; 9: 2401-2408
[3] Lu Y, He K, Qiu B, et al. Sleep quality and health-related quality of life in children who survived for more than 5 years after liver transplantation. J Dig Dis, 2020; 21(11): 668-670
[4] Lu Y, He K, Zhu J, et al. Long-term Outpatient Management of Pediatric Patients After Liver Transplantation. Ann Transplant, 2021; 26: e933806
[5] Zheng Z, Lu Y, Wang M, et al. Low COVID-19 vaccine coverage and guardian acceptance among pediatric transplant recipients. J Med Virol, 2023; 95(1): e28377
[6] Zhu X, Lu Y, Xue F, et al. SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort. Virol J, 2023; 20(1): 28
[7] Lu Y, Fu J, He K. Managing blood glucose levels in pediatric patients following liver transplantation. Asian J Surg, 2023; 46(11):5042.
[8] Lin D, Lu Y, Qiu B, et al. The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: a prospective cohort. J Clin Lipidol, 2024; 18(6):e1055-e1066
[9] Lu Y, Fu J, He K. Bridging the gap: Enhancing follow-up care for pediatric liver transplant recipients. Asian Journal of Surgery, 2025, https://doi.org/10.1016/j.asjsur.2025.02.151